In this context, it is interesting to note that a variety of genome-wide association studies of BRCA1/2 mutation carriers recently identified some genetic loci, which affect BRCA1/2-associated cancer risks for breast and ovarian cancers [19]–[21]. This evidence concerns the gene BRCA1 and cancer.